Northern Trust Corp Anixa Biosciences Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Northern Trust Corp holds 71,040 shares of ANIX stock, worth $191,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,040

Previous 71,040 -0.0%

Holding current value

$191,097

Previous $156,000 42.95%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.21 - $3.35 $18,515 - $28,066	8,378 Added 13.37%	71,040 $156,000
Q1 2024 May 14, 2024	BUY	$3.08 - $5.02 $34,388 - $56,048	11,165 Added 21.68%	62,662 $195,000
Q4 2023 Feb 13, 2024	SELL	$2.85 - $4.19 $5,548 - $8,157	-1,947 Reduced 3.64%	51,497 $199,000
Q3 2023 Nov 13, 2023	SELL	$2.97 - $3.87 $1,241 - $1,617	-418 Reduced 0.78%	53,444 $174,000
Q2 2023 Aug 11, 2023	SELL	$3.0 - $5.97 $13,833 - $27,527	-4,611 Reduced 7.89%	53,862 $172,000
Q1 2023 May 15, 2023	SELL	$3.86 - $5.0 $162 - $210	-42 Reduced 0.07%	58,473 $251,000
Q3 2022 Nov 14, 2022	BUY	$2.81 - $6.15 $4,487 - $9,821	1,597 Added 2.81%	58,515 $288,000
Q1 2022 May 13, 2022	SELL	$2.5 - $3.42 $8,277 - $11,323	-3,311 Reduced 5.5%	56,918 $156,000
Q4 2021 Feb 08, 2022	SELL	$2.88 - $5.5 $3,032 - $5,791	-1,053 Reduced 1.72%	60,229 $179,000
Q2 2021 Aug 13, 2021	BUY	$3.46 - $4.92 $42,194 - $59,999	12,195 Added 24.84%	61,282 $238,000
Q1 2021 May 12, 2021	SELL	$3.27 - $7.14 $667 - $1,456	-204 Reduced 0.41%	49,087 $230,000
Q4 2020 Feb 11, 2021	SELL	$1.94 - $3.19 $5,278 - $8,679	-2,721 Reduced 5.23%	49,291 $151,000
Q3 2020 Nov 16, 2020	BUY	$1.79 - $3.3 $11,260 - $20,760	6,291 Added 13.76%	52,012 $127,000
Q2 2020 Aug 14, 2020	SELL	$1.53 - $3.06 $12,241 - $24,483	-8,001 Reduced 14.89%	45,721 $140,000
Q1 2020 May 14, 2020	BUY	$1.35 - $4.06 $135 - $405	100 Added 0.19%	53,722 $86,000
Q4 2019 Feb 14, 2020	SELL	$2.78 - $4.03 $6,591 - $9,555	-2,371 Reduced 4.23%	53,622 $176,000
Q3 2019 Nov 13, 2019	SELL	$3.53 - $4.7 $10,590 - $14,100	-3,000 Reduced 5.09%	55,993 $224,000
Q1 2019 May 13, 2019	BUY	$3.85 - $5.53 $1,301 - $1,869	338 Added 0.58%	58,993 $267,000
Q4 2018 Feb 12, 2019	BUY	$3.37 - $6.59 $197,667 - $386,536	58,655 New	58,655 $231,000

Others Institutions Holding ANIX

# of Institutions

Shares Held

5.56M

Call Options Held

21K

Put Options Held

6.7K

View Full List

About Anixa Biosciences Inc

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $82.5M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

More about ANIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Anixa Biosciences Inc Transaction History